It's on the AFR site but looks to be behind a paywall. Dated 7/11/24
"Drugmaker Mayne Pharma Group, which has lost 59 per cent of its share market value over the past five years, is giving some thought to life away from the ASX boards."
I think the OP is worried that Mayne are the manufacturing partner for Spontan (along with APTAR). Not sure how this will effect LTP even if someone does take them over.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $33.02M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 31.0¢ | 28.5¢ | $112.8K | 382.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19244 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 64264 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |